← Top Holdings

NBIXNeurocrine Biosciences, Inc.

CUSIP: 64125C109

2

Guru Owners

$739.0M

Total Value Held

5.6M

Total Shares

$719.4M
0.40%
$19.5M
0.09%

📊 Fundamentals

Market Cap$17.8B
P/E Ratio27.3x
Above market avg
Forward P/E14.1x
P/FCF30.2x
EPS (TTM)$6.49
Revenue (TTM)$3.1B
Profit Margin21.55%
Beta0.39

52-Week Range

$122.14
$178.75

Current: $177.49

Data from Yahoo Finance · refreshed every 4 hours

💡 Trades at 27.3x trailing earnings → 14.1x forward · 21.6% profit margin

📊 Holdings Over Time

How superinvestor ownership has changed across quarters

$0$200.6M$401.2M$601.9M$802.5MQ4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26

Quarter-by-Quarter Activity

Q1 '262 owners · $739.0M
REDUCEDDodge & Cox$719.4M
REDUCEDRay Dalio$19.5M
Q4 '252 owners · $802.5M
REDUCEDDodge & Cox$781.2M
REDUCEDRay Dalio$21.3M
Q3 '252 owners · $783.3M
REDUCEDDodge & Cox$780.0M
REDUCEDRay Dalio$3.2M
Q2 '252 owners · $700.8M
INCREASEDDodge & Cox$699.7M
INCREASEDRay Dalio$1.1M
Q1 '252 owners · $621.8M
INCREASEDDodge & Cox$612.1M
INCREASEDRay Dalio$9.6M
Q4 '242 owners · $457.1M
NEWDodge & Cox$411.7M
INCREASEDRay Dalio$45.4M

💰 DCF Calculator

DCF model · 10-yr forecast

Estimates depend entirely on your assumptions. Adjust the inputs below to explore scenarios.

📊 Adjust the assumptions below to calculate an estimated fair value
Projection Period
Revenue Growth Rate
19%analyst est. 18.5%
0%100%
Growth Decay Rate
15%
0% (no decay)50% (fast decay)
Terminal Growth Rate
3.0%
0%5%
FCF Margin
19.0%current: 19.0%
1%50%
Discount Rate (WACC)
8.0%typical: 8% large caps · 10% growth
5%20%

Model: 10-year DCF · 3.0% terminal growth · Based on Yahoo Finance data

🏛️ Congressional Trades

NBIX: Held by 2 superinvestors · 3 congress member trades

$1,001 - $15,0002025-06-17
$1,001 - $15,0002025-06-11
$15,001 - $50,0002024-11-19
NBIX Institutional Ownership — Superinvestor Holdings | Superinvestor 13F Tracker